<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="drugDebug/PMC6792045/results/search/funder/results.xml">
  <result pre="of Shandong ProvinceZR2018PC012ZR2015CL033 Projects of medical and health technology development" exact="program" post="in Shandong province2015WS0123 Taishan Scholars program of Shandong Provincets201511056"/>
  <result pre="and health technology development program in Shandong province2015WS0123 Taishan Scholars" exact="program" post="of Shandong Provincets201511056 This work was supported by the"/>
  <result pre="numbers ZR2018PC012, ZR2015CL033], Projects of medical and health technology development" exact="program" post="in Shandong province, China [grant number 2015WS0123] and W.S."/>
  <result pre="number 2015WS0123] and W.S. was supported by the Taishan Scholars" exact="program" post="of Shandong Province, China [grant number ts201511056]. fig-count: table-count:"/>
  <result pre="twice (Late stage treatment). Discussion The infection model provides a" exact="foundation" post="for the evaluation of the efficacy of novel antiviral"/>
  <result pre="vitro and in vivo. This neonatal murine model lays a" exact="foundation" post="for studying the pathogenesis of CVA4 and for evaluating"/>
 </snippets>
</snippetsTree>
